Front Row Advisors’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02K Buy
24
+2
+9% +$146 ﹤0.01% 511
2026
Q1
$1.44K Hold
22
﹤0.01% 517
2025
Q4
$1.74K Hold
22
﹤0.01% 494
2025
Q3
$1.61K Hold
22
﹤0.01% 496
2025
Q2
$1.67K Hold
22
﹤0.01% 474
2025
Q1
$1.67K Hold
22
﹤0.01% 451
2024
Q4
$1.45K Hold
22
﹤0.01% 454
2024
Q3
$1.53K Sell
22
-19
-46% -$1.14K ﹤0.01% 452
2024
Q2
$2.17K Buy
+41
New +$2.49K ﹤0.01% 846

Other funds holding SOLV

Front Row Advisors's SOLV Position: Q2 2026 in Review

Front Row Advisors increased its Solventum (SOLV) stake by 9.1% in Q2 2026, buying an estimated $146 and bringing the position to 24 shares worth $2.02K. The position accounts for ﹤0.01% of the portfolio, ranked #511.

Front Row Advisors first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.17K in Q2 2024. 881 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Front Row Advisors held 24 shares of Solventum worth $2.02K as of Q2 2026.
  • Front Row Advisors bought 2 Solventum shares in Q2 2026, an estimated $146.
  • Solventum made up ﹤0.01% of Front Row Advisors's portfolio in Q2 2026, its #511 holding.
  • Front Row Advisors first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Front Row Advisors's Solventum position peaked at $2.17K in Q2 2024.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Front Row Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.